Sientra Stock Price Target and Analyst Ratings (NASDAQ:SIEN)

Analyst Price Target for SIEN

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

^$8.20

▲ +15.17% Upside Potential

This price target is based on 6 analysts offering 12 month price targets for Sientra in the last 3 months. The average price target is $8.20, with a high forecast of $11.00 and a low forecast of $5.00. The average price target represents a 15.17% upside from the last price of $7.12.

Buy

The current consensus among 6 polled investment analysts is to buy stock in Sientra. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

0 strong buy ratings
8 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

9/15/2019

0 strong buy ratings
8 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

12/14/2019

0 strong buy ratings
9 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

3/13/2020

0 strong buy ratings
6 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

6/11/2020

0 strong buy ratings
6 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

9/9/2020

0 strong buy ratings
6 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

12/8/2020

0 strong buy ratings
6 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

2/6/2021

0 strong buy ratings
6 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

3/8/2021

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price	Details
2/5/2021	Maxim Group	Reiterated Rating	Buy	$11.00	High	i Rating by Anthony Vendetti at Maxim Group
2/5/2021	Canaccord Genuity	Boost Price Target	Buy	$6.00 ➝ $8.00	High	i
11/10/2020	William Blair	Reiterated Rating	Outperform		Low	i Rating by M. Kaczor at William Blair
11/10/2020	SVB Leerink	Boost Price Target	Outperform	$6.00 ➝ $8.00	High	i
8/14/2020	Canaccord Genuity	Reiterated Rating	Buy	$6.00	High	i
8/12/2020	Maxim Group	Reiterated Rating	Buy	$8.00	High	i
8/11/2020	SVB Leerink	Boost Price Target	Outperform	$5.30 ➝ $6.00	High	i
6/11/2020	Maxim Group	Boost Price Target		$5.00 ➝ $8.00	Low	i
5/15/2020	Canaccord Genuity	Lower Price Target	Buy	$9.00 ➝ $5.00	Medium	i
5/12/2020	SVB Leerink	Lower Price Target	Outperform	$6.50 ➝ $5.30	High	i
3/23/2020	Stephens	Lower Price Target	Overweight	$10.00 ➝ $5.00	High	i
3/12/2020	Craig Hallum	Lower Price Target	Buy	$14.00 ➝ $9.00	High	i
3/12/2020	SVB Leerink	Lower Price Target	Outperform	$13.00 ➝ $6.50	High	i
3/12/2020	Canaccord Genuity	Lower Price Target	Buy	$13.00 ➝ $9.00	High	i Rating by Kyle Rose at Canaccord Genuity
3/12/2020	Maxim Group	Lower Price Target	Buy	$12.00 ➝ $8.00	High	i
3/12/2020	Stephens	Lower Price Target	Overweight	$14.00 ➝ $10.00	High	i
11/5/2019	William Blair	Upgrade	Market Perform ➝ Outperform		Medium	i Rating by M. Kaczor at William Blair
9/24/2019	Canaccord Genuity	Set Price Target	Buy	$13.00	High	i Rating by Kyle Rose at Canaccord Genuity
8/9/2019	Stephens	Set Price Target	Buy	$16.00	Low	i Rating by Chris Cooley at Stephens
8/9/2019	Canaccord Genuity	Boost Price Target	Buy	$11.00 ➝ $13.00	N/A	i
8/9/2019	Maxim Group	Reiterated Rating	Buy ➝ Buy	$16.00 ➝ $12.00	High	i
7/25/2019	Craig Hallum	Lower Price Target	Buy	$20.00 ➝ $14.00	Medium	i Rating by Alexander Nowak at Craig Hallum
6/5/2019	Wells Fargo & Company	Upgrade	Market Perform ➝ Outperform	$8.00 ➝ $10.00	High	i Rating by David Maris at Wells Fargo & Company
4/22/2019	Craig Hallum	Set Price Target	Buy	$23.00	Low	i Rating by Alexander Nowak at Craig Hallum
3/26/2019	Craig Hallum	Set Price Target	Buy	$23.00	High	i Rating by Alexander Nowak at Craig Hallum
3/14/2019	Wells Fargo & Company	Initiated Coverage	Market Perform	$9.00	High	i
3/13/2019	Stifel Nicolaus	Lower Price Target	Buy	$19.00 ➝ $16.00	Medium	i
3/13/2019	Dougherty & Co	Lower Price Target	Buy	$29.00 ➝ $27.00	High	i
3/13/2019	SVB Leerink	Lower Price Target		$22.00 ➝ $18.00	High	i
3/13/2019	William Blair	Downgrade	Outperform ➝ Market Perform		High	i Rating by M. Kaczor at William Blair
2/11/2019	Maxim Group	Reiterated Rating	Buy	$20.00	Medium	i
12/19/2018	Maxim Group	Upgrade	Hold ➝ Buy		Low	i
8/30/2018	Dougherty & Co	Initiated Coverage	Buy ➝ Buy	$31.00	Medium	i Rating by K. Bauser at Dougherty & Co
8/9/2018	Stephens	Reiterated Rating	Buy	$30.00	High	i
8/8/2018	Stifel Nicolaus	Boost Price Target	Buy ➝ Buy	$21.00 ➝ $25.00	High	i
8/8/2018	Canaccord Genuity	Boost Price Target	Buy	$19.00 ➝ $25.00	High	i
6/4/2018	Craig Hallum	Initiated Coverage	Buy	$23.00	High	i
5/10/2018	Canaccord Genuity	Reiterated Rating	Buy	$19.00	High	i
4/27/2018	Lake Street Capital	Upgrade	Hold ➝ Buy	$16.00	Low	i Rating by R. Department at Lake Street Capital
4/26/2018	Maxim Group	Boost Price Target	Buy ➝ Buy	$15.00 ➝ $19.00	Low	i
4/20/2018	SVB Leerink	Reiterated Rating	Outperform		High	i Rating by R. Newitter at SVB Leerink LLC
4/19/2018	Canaccord Genuity	Reiterated Rating	Buy	$18.00	High	i
4/19/2018	Lake Street Capital	Boost Price Target	Hold ➝ Hold	$11.00 ➝ $13.00	High	i Rating by R. Department at Lake Street Capital
3/22/2018	Maxim Group	Initiated Coverage	Buy ➝ Buy	$15.00	High	i
3/14/2018	Canaccord Genuity	Lower Price Target	Buy ➝ Buy	$19.00 ➝ $18.00	Low	i
3/1/2018	William Blair	Reiterated Rating	Buy		Low	i Rating by M. Kaczor at William Blair
2/21/2018	Lake Street Capital	Downgrade	Buy ➝ Hold	$15.00 ➝ $11.00	High	i Rating by R. Department at Lake Street Capital
1/19/2018	Stifel Nicolaus	Upgrade	Hold ➝ Buy	$14.00	High	i
1/5/2018	Canaccord Genuity	Reiterated Rating	Buy	$19.00	High	i
10/8/2017	Canaccord Genuity	Reiterated Rating	Buy	$14.00	N/A	i
9/27/2017	Stifel Nicolaus	Reiterated Rating	Hold ➝ Hold	$11.00 ➝ $14.00	High	i
9/13/2017	William Blair	Upgrade	Market Perform ➝ Outperform		High	i Rating by M. Kaczor at William Blair
8/28/2017	Canaccord Genuity	Initiated Coverage	Buy ➝ Buy	$14.00	High	i
8/8/2017	Lake Street Capital	Reiterated Rating	Buy	$11.00 ➝ $15.00	Low	i
8/2/2017	Lake Street Capital	Reiterated Rating	Buy ➝ Buy	$11.00 ➝ $15.00	High	i
7/11/2017	Stephens	Initiated Coverage	Overweight	$12.00	High	i
4/17/2017	Lake Street Capital	Initiated Coverage	Buy ➝ Buy	$11.00	High	i
8/10/2016	William Blair	Reiterated Rating	Market Perform		N/A	i Rating by M. Kaczor at William Blair

(Data available from 3/8/2016 forward)

Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products to plastic surgeons in the United States. It operates through two segments, Breast Products and miraDry. The company offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra, AlloX2, OPUS, Dermaspan, Softspan, and BIOCORNEUM brand names. It also provides body contouring products; facial and nasal implants; saline filled breast implant sizers; and miraDry System, a non-surgical device for the permanent reduction of underarm sweat, odor, and hair of all colors. The company was formerly known as Juliet Medical, Inc. and changed its name to Sientra, Inc. in April 2007. Sientra, Inc. was incorporated in 2003 and is headquartered in Santa Barbara, California.

Today's Range

Now: $7.12

$6.62

$7.24

50 Day Range

MA: $6.35

$4.39

$8.59

52 Week Range

Now: $7.12

$1.00

$8.93

Volume

79,486 shs

Average Volume

1,263,839 shs

Market Capitalization

$359.23 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.81

Frequently Asked Questions

What sell-side analysts currently cover shares of Sientra?

The following Wall Street sell-side analysts have issued research reports on Sientra in the last year: Canaccord Genuity, Craig Hallum, Maxim Group, Stephens, SVB Leerink LLC, William Blair, and Zacks Investment Research.
View the latest analyst ratings for SIEN.

What is the current price target for Sientra?

5 Wall Street analysts have set twelve-month price targets for Sientra in the last year. Their average twelve-month price target is $8.20, suggesting a possible upside of 15.2%. Maxim Group has the highest price target set, predicting SIEN will reach $11.00 in the next twelve months. Stephens has the lowest price target set, forecasting a price of $5.00 for Sientra in the next year.
View the latest price targets for SIEN.

What is the current consensus analyst rating for Sientra?

Sientra currently has 6 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe SIEN will outperform the market and that investors should add to their positions of Sientra.
View the latest ratings for SIEN.

What other companies compete with Sientra?

Other companies that are similar to Sientra include Inogen, Invacare, Milestone Scientific, Lakeland Industries, United Health Products, Nutriband, Surgalign, Sanara MedTech, Alpha Pro Tech, ReWalk Robotics, Conformis, CollPlant Biotechnologies, Myomo, Predictive Oncology and Allied Healthcare Products.

How do I contact Sientra's investor relations team?

Sientra's physical mailing address is 420 SOUTH FAIRVIEW AVENUE SUITE 200, SANTA BARBARA CA, 93117. The medical instruments supplier's listed phone number is 805-562-3500 and its investor relations email address is [email protected] The official website for Sientra is www.sientra.com.

NASDAQ:SIEN - Sientra Stock Price Target and Predictions

Analyst Price Target for SIEN

Past Monthly Recommendations

Latest Recommendations

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Frequently Asked Questions

What sell-side analysts currently cover shares of Sientra?

What is the current price target for Sientra?

What is the current consensus analyst rating for Sientra?

What other companies compete with Sientra?

How do I contact Sientra's investor relations team?